Patients with chronic HBV-related hepatitis are typically treated long-term with nucleoside/nucleotide analog antiviral therapy, and treatment may be discontinued based on HBV DNA and ALT levels as well as liver fibrosis assessment. Here, GPT is linked to Hepatic fibrosis.